Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada
· Delayed Price · Currency is CAD 8.54
+0.48 (5.96%)
At close: Dec 5, 2025
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 432.54 million as of December 5, 2025. Its market cap has increased by 156.71% in one year.
Market Cap
432.54M
Enterprise Value
350.82M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.54
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 432.54M, an increase of 454.49%. That is a compound annual growth rate of 43.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 432.54M | 169.23% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.62B |
| Green Thumb Industries | 2.22B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.91B |
| Extendicare | 1.85B |
| Trulieve Cannabis | 1.48B |
| Cronos Group | 1.34B |
| WELL Health Technologies | 1.01B |